Many Patients Perceive Lack of Choice in Receiving RAI for Thyroid Cancer
Many patients diagnosed with differentiated thyroid cancer perceive that they have no choice about receiving radioactive iodine.
Thyroid Cancer
Case Study: Tingling and Numbness After Thyroid Cancer Surgery
A woman who underwent total thyroidectomy with neck dissection experiences headaches, muscle spasms, and cramps.
Extranodal Extension May Indicate Intermediate Recurrence Risk in Papillary Thyroid Carcinoma
When the investigators included extranodal extension in the ATA’s current PTC risk stratification system, 32.8% of patients originally categorized as low risk with ≤5 positive lymph nodes were increased to intermediate risk.
Increased Incidence of Pediatric Thyroid Cancer in the United States
Incidence rates of pediatric thyroid cancer have increased in the United States, likely attributable to enhanced diagnostic practices and an increase in thyroid cancer in the pediatric population.
Overall Cancer Risk Increased in Patients With Type 2 Diabetes
Standardized incidence ratio highest for prostate cancer for men, nasopharynx cancer for women
Once-Weekly Exenatide Treatment Does Not Increase Risk for Medullary Thyroid Carcinoma
Treatment with once-weekly exenatide 2 mg does not increase serum calcitonin concentrations or the risk for medullary thyroid carcinoma.
Cumulative Risk for Thyroid Cancer After Initial Benign Thyroid Biopsy
Patients who initially received negative thyroid biopsy results might face higher cumulative risk of developing thyroid cancer than that projected in previous literature.
Complication Rates Low for High-Volume Pediatric Thyroid Surgery
Complication rates are low following surgery for pediatric thyroid disease at a high-volume center.
Thyroid Cancer: Individualized Follow-Up Curtails Unnecessary Tests
In patients who have had successful thyroid cancer treatment, clinicians should consider scaling back extensive follow-up testing.
Active Surveillance: Is it an Appropriate Approach for Thyroid Cancer?
In patients with thyroid cancer, active surveillance has been controversial because surgery is the standard of care.
